Word: phased
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...this is healthy? No, I wouldn't say healthy. What we said coming into 2009 is that stocks would enter a base-building phase that would, over time, heal the technical damage done to the market in 2008. What base-building means is that you go into a trading range. But we also could have some very exciting rallies in the process of base-building...
Frederick "Fritz" Henderson will not have the luxury of a honeymoon phase. The new interim CEO of General Motors - whose predecessor, Rick Wagoner, resigned March 29 at the behest of the White House - inherits a company in disarray. Over the next 60 days, Henderson must engineering some kind of comeback for the sputtering carmaker, amid the glare of the media spotlight and mounting public outrage over disappearing auto jobs. (Read "Will Wagoner's Exit Put GM on the Road to Recovery...
...moving through the classic Kubler-Ross cycle of dealing with a terminal diagnosis. Old media has already gone through Denial and Anger, and are now Bargaining, looking for ways to beat the Grim Reaper. "Most of the product ideas that you all are coming up with in this bargaining phase don't make any sense from the customer viewpoint," he told me recently. "Anything that falls into the category of 'the web doesn't pay well enough and so we need to gin up some alternative that will pay better' is going to fail - people aren't stupid." All that...
...This was the approach used by VaxGen's AIDSVax, the only AIDS vaccine candidate that has so far made it to Phase III testing, the final stage before clinical approval. That vaccine was designed to spark an immune response to a surface protein called gp120. But results of that trial showed in 2003 that the vaccine was insufficiently effective. To date, dozens of possible AIDS vaccines have been tested, and none seem especially promising...
...Today there are a few other candidates in early phase trials, including compounds of two previously tested candidates, just in case they turn out to be effective together where each failed individually. Since Merck's setback in 2007, however, some scientists have questioned current vaccine-development tactics. And some researchers, including those in Nussenzweig's lab, are now trying to produce HIV immunity through antibodies; but despite good results in primates, they have had no luck so far in humans with a single-antibody vaccine...